- Home
- GSHR vs LYEL Comparison
GSHR vs LYEL Comparison
Compare GSHR & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSHR
- LYEL
- Stock Information
- Founded
- GSHR 2024
- LYEL 2018
- Country
- GSHR United States
- LYEL United States
- Employees
- GSHR N/A
- LYEL N/A
- Industry
- GSHR
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- GSHR
- LYEL Health Care
- Exchange
- GSHR NYSE
- LYEL Nasdaq
- Market Cap
- GSHR 205.8M
- LYEL 207.7M
- IPO Year
- GSHR 2025
- LYEL 2021
- Fundamental
- Price
- GSHR $10.06
- LYEL $9.74
- Analyst Decision
- GSHR
- LYEL Sell
- Analyst Count
- GSHR 0
- LYEL 2
- Target Price
- GSHR N/A
- LYEL $20.00
- AVG Volume (30 Days)
- GSHR 4.7K
- LYEL 229.7K
- Earning Date
- GSHR 01-01-0001
- LYEL 08-06-2025
- Dividend Yield
- GSHR N/A
- LYEL N/A
- EPS Growth
- GSHR N/A
- LYEL N/A
- EPS
- GSHR N/A
- LYEL N/A
- Revenue
- GSHR N/A
- LYEL $65,000.00
- Revenue This Year
- GSHR N/A
- LYEL N/A
- Revenue Next Year
- GSHR N/A
- LYEL N/A
- P/E Ratio
- GSHR N/A
- LYEL N/A
- Revenue Growth
- GSHR N/A
- LYEL N/A
- 52 Week Low
- GSHR $9.97
- LYEL $7.65
- 52 Week High
- GSHR $10.25
- LYEL $53.30
- Technical
- Relative Strength Index (RSI)
- GSHR N/A
- LYEL 50.46
- Support Level
- GSHR N/A
- LYEL $8.96
- Resistance Level
- GSHR N/A
- LYEL $13.73
- Average True Range (ATR)
- GSHR 0.00
- LYEL 1.90
- MACD
- GSHR 0.00
- LYEL 0.04
- Stochastic Oscillator
- GSHR 0.00
- LYEL 33.98
About GSHR GESHER ACQUISITION CORPORATION II ORD USD0.0001 CL A
Gesher Acquisition Corp II is a blank check company.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.